BioCentury
ARTICLE | Clinical News

Febuxostat regulatory update

July 13, 2015 7:00 AM UTC

The European Commission approved an expanded label for Adenuric febuxostat from Menarini to include the prevention and treatment of hyperuricemia in adults undergoing chemotherapy for hematologic mali...